Companies · Healthtech

Zealth, Inc.Winter 2021Active

SAN MATEO · KA, India; Remote · Healthtech · refined from filed group “Other Technology · founded 2021 · https://zealth-ai.com/

Diligence memoA one-page analyst read on Zealth, Inc. — recommendation, valuation, rhythm, risks.
$95.0M
Total raised · real
1
Rounds
Latest step-up
Top 5%
Sector rank · raised
Series C
Latest stage · inferred · Wed Oct 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Zealth, Inc. looks over-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the healthtech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 1.55× the median modeled value of Series C Healthtech companies in 2019–2021 (33 peers) — value vs value, same stage and era.
Dormant
  • Last raise 4.7 yr ago; this sector typically re-raises about every 14 months.
  • Only one round on record and long silent — often defunct, acquired, or gone quiet.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Healthtech

Zealth, Inc. is one of 2138 Healthtech companies tracked from SAN MATEO, KA, India; Remote, on record since 2021. By capital raised it ranks among the largest (ahead of 96% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

AI analyst read est. — model-extracted from this company's public description, not a verified fact. 30%

operates a technology-led product inferred from public copy

Grounded in: “You are a venture analyst

Software for remote monitoring of cancer patients

Zealth is building remote monitoring software to help hospitals provide automated continuous round-the-clock support to their cancer patients post-discharge. Hospitals are overburdened with no resources to provide care to their chronic patients once they leave the hospital. For instance, in India, there are only 2200 oncologists for 1.38 billion people. Patients travel 100 miles waiting for hours to get few minutes with the doctors. They have no easy means to manage all the toxicities and symptoms they get once they are back home. This leads to 6X lower patient retention, 4X high emergency readmissions, and poor patient outcomes. Zealth bridges this gap through its digital health intervention platform.

Health TechOncologyRemotehealthtech
Find Zealth, Inc. online

As reported in public records reported — not modeled.

IN
Jurisdiction
Rule 506(b)
Reg D exemption
8
Investors (latest)
2017
Year incorporated
2021-10-27
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$500M$1.0B$1.5B$2.0BSeries C · 2021-10-27 Raised $95M (real) Modeled valuation $1.7B (est)$95M$1.7BSeries C2021

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series C$95.0M · 2021

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series A, Series B — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 20%.

Modeled valuation trajectory
$1.7B
Base estimate est.
$345.3M
Conservative case
$3.7B
Upside case
$633.3M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ca $40M–$100M round). Valuation is modeled from stage benchmarks scaled by the healthtech sector profile. Directional, not a quoted figure.

Not enough modeled valuation points to chart a trajectory.

Model inputs · modeled:benchmark-stage-stepup-v1
15%
Dilution assumption
Implied ownership sold in the financing.
73%
Survival probability
55% low · 85% high
1.32×/yr
Annual markup
1.51×/yr upside case
4.7 yr
Elapsed time used
4.7 yr actual, capped for stale marks
healthtech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
Avg between rounds
Capital velocity
4.7 yr
On record since
2021
First round
1
Rounds on file
How it compares to the market

Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 21× above median
This company$95.0M
Sector median$4.5M
Latest round — vs other Series C rounds in sector (real $, this stage) 2.0× above median
This company$95.0M
Sector median$46.5M
Modeled value — vs sector median (estimate, all stages) 50× above median
This company$1.7B
Sector median$33.8M

Raised more than 96% of sector peers (real $). Modeled value above 99% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series C) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #4 of 33.

This companyCohort peer
$1.0B$10.0B$10.0M$100.0M$1.0BCapital raised (log)Virta Health Corp. · Series C Raised $122.0M · modeled $2.4B (est)Fresenius Medical Care Voorhees, LLC · Series C Raised $71.1M · modeled $1.8B (est)Clear Health Pass Holdings LLC · Series C Raised $100.0M · modeled $1.8B (est)Jawbone Health Hub, Inc. · Series C Raised $65.4M · modeled $1.7B (est)Boston Health Economic Holdings, LLC · Series C Raised $63.0M · modeled $1.6B (est)PWN Health Holdings, Inc. · Series C Raised $61.8M · modeled $1.5B (est)Quartet Health, Inc. · Series C Raised $127.0M · modeled $1.4B (est)Workit Health, Inc. · Series C Raised $87.9M · modeled $1.4B (est)Ajax Health II LLC · Series C Raised $51.0M · modeled $1.3B (est)Eden Health, Inc. · Series C Raised $73.4M · modeled $1.3B (est)NeuSpera Medical Inc. · Series C Raised $88.6M · modeled $1.3B (est)Zealth, Inc. (this company) Raised $95.0M · modeled $1.7B (est)Zealth, Inc.
CompanyStageRaised · realValue · estvs peer med.
Virta Health Corp.Series C$122.0M$2.4B2.19×
Fresenius Medical Care Voorhees, LLCSeries C$71.1M$1.8B1.67×
Clear Health Pass Holdings LLCSeries C$100.0M$1.8B1.67×
Zealth, Inc. this companySeries C$95.0M$1.7B1.55×
Jawbone Health Hub, Inc.Series C$65.4M$1.7B1.54×
Boston Health Economic Holdings, LLCSeries C$63.0M$1.6B1.48×
PWN Health Holdings, Inc.Series C$61.8M$1.5B1.39×
Quartet Health, Inc.Series C$127.0M$1.4B1.28×
Workit Health, Inc.Series C$87.9M$1.4B1.27×
Ajax Health II LLCSeries C$51.0M$1.3B1.20×
Eden Health, Inc.Series C$73.4M$1.3B1.19×
NeuSpera Medical Inc.Series C$88.6M$1.3B1.19×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series C$95.0M2021-10-27$633.3M$1.7B90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series C$95.0M2021-10-27
    • First recorded raise — entered as Series C.
    • 8 investors on this round.
Intelligence
Modeled next raise
$152.0M
Modeled next size est.range $98.8M$243.2M
Last step-up
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Carl Byers6 other2021-10
Justin White2 other2021-10
Adam Ting2021-10
Pranay Kapadia2021-10
Registry & provenance

Zealth, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
IN
Jurisdiction
1892475
SEC CIK
2017
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Quartet Health, Inc.HealthtechSeries C$127.0M$1.4Bnetwork1 shared operator · same sector · same stage
Akura Medical, Inc.HealthtechSeries C$94.8M$299.4Msame sector · same stage
Magnolia Medical Technologies, Inc.HealthtechSeries C$94.2M$727.7Msame sector · same stage
Elevate Care International Topco LPHealthtechSeries C$98.4M$1.0Bsame sector · same stage
Clear Health Pass Holdings LLCHealthtechSeries C$100.0M$1.8Bsame sector · same stage
Freedom Dental Funding, LLCHealthtechSeries C$100.0M$1.1Bsame sector · same stage
Genome Medical Holding CoHealthtechSeries C$90.0M$605.8Msame sector · same stage
HighFive Healthcare TopCo, LLCHealthtechSeries C$100.7M$600.8Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Spire Health
Remote patient monitoring for lung disease patients.
Medical Devices76%
Clinikally
India's Telemedicine Platform & Online Pharmacy for Dermatology Care
Healthtech76%
Transradial Technologies, Inc.Software / TechPre-Seed$1.4M76%
Zeal Analytics, Inc.Software / TechPre-Seed$6.1M75%
Life Detection Technologies, Inc.Software / TechSeed$5.1M74%
JenaValve Technology IncSoftware / TechSeries D+$2.2B74%
Zea Health, Inc.HealthtechSeed$7.3M74%
Zakipoint Health, Inc.HealthtechSeed$13.9M73%
Frequently asked
How much funding has Zealth, Inc. raised?
Zealth, Inc. has raised approximately $95.0M in disclosed capital across 1 recorded financing round, aggregated from public filings.
What is Zealth, Inc.'s estimated valuation?
Provath's modeled valuation for Zealth, Inc. is approximately $1.7B (modeled range $345.3M–$3.7B). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Zealth, Inc. at?
Zealth, Inc.'s latest modeled financing stage is Series C. Its most recent recorded round closed around Wed Oct 27.
What does Zealth, Inc. do and where is it based?
Zealth, Inc. operates in the Healthtech sector, based in SAN MATEO, KA, India; Remote. Software for remote monitoring of cancer patients
Explore related

See where Zealth, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Zealth, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.